Our Advocacy Statements

Comment to Meta’s Oversight Board in the Case of ‘India Sexual Harassment Video (2022-012-IG-MR)’

2022

Oversight Board is an external, independent body created by Meta that people can appeal to if they disagree with Meta’s content enforcement decisions on Facebook or Instagram. Out of the appeals it receives, the Case Selection Committee of the Board will select the cases that the Board will hear based on some criteria that it sets (e.g.,…

Cross-Border ‘Data Flow With Data Rights’

2022

Cross-border data flows are the most hotly contested issue globally in terms of digital trade. IT for Change proposes a new framework to govern cross-border data flows, 'Data Flow with Data Right', which in our view should assure developing countries that their concerns, especially economic and sovereignty-related, are being taken on board.…

Submission to the NHA on the Data Sharing Guidelines draft for PM-JAY

2022

The National Health Authority (NHA) recently released its Data Sharing Guidelines draft for PM-JAY. The NHA invited responses and comments from the public and as such IT for Change duly sent in its recommendations. While the NHA's proposal is certainly a step in the right direction, there are a few key points that we feel needs addressing.…

Submission to MeitY on Part-I and Part-II of the IT (Intermediary Guidelines and Digital Media Ethics Code) Rules, 2021

2022

The Ministry of Electronics and Information Technology (MeitY) has proposed amendments to the Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Rules, 2021. With an aim to increase platform accountability, the proposed amendments focus heavily on stemming the virality of harmful content.

We believe that the…

Inputs from IT for Change to MeitY on the Draft National Data Governance Framework Policy

2022

This is IT for Change’s response to the draft National Data Governance Framework Policy (NDGFP) released for public consultation by the Ministry of Electronics and Information Technology (MeitY) in May 2022. Given that the NDGFP is not very different from the draft Data Accessibility and Use Policy released in February 2022, this response must…

Joint CSO post-MC12 Statement on Access to Medicine

2022

IT for Change signed the post-MC12 statement on access to medicine, which includes over 100 groups on it thus far, including Public Services International (PSI), Focus on the Global South, African Alliance, Vaccine Advocacy Resource Group, World Federation of Public Health Associations, Health Justice International (HJI), People's Health…

Submission on Online Violence Against Women To the Special Rapporteur on Violence against Women

2017

Drawing from IT for Change’s work, this submission provides an overview of legislative and judicial developments in India with respect to online violence against women. It offers an analysis of the government’s…

Inputs from IT for Change to MeitY on the Draft India Data Accessibility and Use Policy

2022

With our societies getting increasingly digitalized and datafied if governments are to keep fulfilling their central societal role they too must get digitalized and datafied. But this must be undertaken in appropriate ways that protect and enhance people’s rights, requiring strong new institutional checks and balances, on one hand, and new…

IT for Change's Statement at the UNGA on “Frameworks for a peaceful world – promoting peace, international law and digital cooperation"

2022

In September 2021, the United Nations Secretary-General released the 'Our Common Agenda' Report, which aimed to "report back before the end of the seventy-fifth session of the General Assembly with recommendations to advance our common agenda and to respond to current and future challenges". Over the course of February 2022, a series of 5…

CSO's Open Letter to the WTO Director General on the TRIPS Waiver

2021

IT for Change was part of 200 CSOs who have written to the Director General of World Trade Forum, Ngozi Okonjo-Iweala highlighting the importance and urgency to agree on a WTO TRIPSWaiver for diagnostics, therapeutics, and vaccines.

Read the letter here.